About Us
History
Rasta Imen Darou
Rasta Imen Darou was established in 2012 with the aim of providing high-quality pharmaceutical products and specialized supplements to the Iranian healthcare market. In line with this goal, the company has secured exclusive representation from reputable international firms and has partnered with them to transfer technology and manufacture licensed pharmaceutical and supplement products. Rasta Imen Darou is proud to collaborate with leading European and American companies such as APOTEX, AA Pharma, Activa and Arthur Andrew. The company’s product portfolio covers a wide range of therapeutic areas, including endocrinology, respiratory, cardiovascular, rheumatology, and neurology. These products are distributed nationwide, either as imports or under license.
Rasta Imen Darou
Rasta Imen Darou
Mission
Our mission is to advance public health by sourcing and producing world-class medicines and supplements, grounded in cutting-edge science and international standards.
Vision
Our vision is to become one of the most trusted pharmaceutical companies in the region and a benchmark for healthcare innovation by 2030.
Values
Quality
Adherence to the highest quality standards at every stage.
Innovation
Continuous investment in R&D and emerging technologies.
Trust
Transparency and integrity with patients and partners.
Responsibility
Commitment to public health and the environment.
CEO
Dr. Maryam Habibi earned her Doctor of Pharmacy (Pharm.D.) degree from Islamic Azad University in 2002. Her early passion for industrial pharmacy led her to begin her professional career in 1999 at Hakim Pharmaceutical Company, even before completing her studies. With over two decades of impactful experience in the pharmaceutical industry, she has contributed to diverse areas including product R&D, quality control, quality assurance, and regulatory affairs. This broad professional journey has provided her with in-depth expertise in contract manufacturing management, licensed production, and technology transfer. Since 2019, Dr. Habibi has been collaborating with HITCO Holding and in 2022 she was appointed as the CEO of Rasta Imen Darou. With a strong focus on innovation, continuous enhancement of quality standards, and expansion of international collaborations, she plays a pivotal role in advancing the strategic objectives of the Holding.